EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Feasibility of a tailored operative strategy from organ preservation to pelvic exenteration for cT4 rectal cancer depending on neoadjuvant response

Christina Fleming, Deena Harji, Benjamin Fernandez, Marc-Olivier François, Vincent Assenat, Pasticier Gilles, Michiels Clément, Grégoire Robert, Quentin Denost

International Journal of Colorectal Disease · 2024

DOI: 10.1007/s00384-024-04675-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Colorectal Disease, 2024. Verfasst von Christina Fleming und 8 weiteren Autor:innen. Beteiligte Einrichtung: Bordeaux Colorectal Institute, Clinique Tivoli, 220 Rue Mandron, 33000, Bordeaux, France. christina.fleming49@gmail.com. Hauptthemen laut MEDLINE: Pelvic Exenteration, Rectal Neoplasms, Neoadjuvant Therapy, Feasibility Studies. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Improvements in neoadjuvant therapy for locally advanced cT4 rectal cancer have led to improved tumour response and thus a variety of suitable management strategies. The aim of this study was to report management and outcomes of patients with cT4 rectal cancer undergoing a spectrum of treatment strategies from organ preservation (OP) to pelvic exenteration (PE).

Methods

Patients who underwent elective treatment for cT4 rectal cancer between 2016 and 2021 were included. All patients were treated with curative intent. Surgical management was adapted to tumour response. Kaplan–Meier curves were generated to compare 3-year overall survival (3y-OS), local recurrence (3y-LR) and distant metastases (3y-DM) between different strategies.

Results

Among 152 patients included, 13 (8%) underwent OP, 71 (47%) TME and 68 (45%) APR/PE. The median follow-up was 31.3 months. Patients undergoing OP had a lower tumour pretreatment ( p < 0.001). Compared to patients with TME, those with APR/PE had a higher rate of ypT4 ( p = 0.001) with a lower R0 rate ( p = 0.044). The 3y-OS and 3y-DM were 78% and 15.1%, respectively, without significant differences. The 3y-LR was 6.6%, and patients with OP had a significantly worse 3y-local regrowth compared to 3y-LR in patients with TME and APR/PE (30.2% vs. 5.4% vs. 2%, p = 0.008). Conclusion cT4 tumours may be suitable for the full spectrum of rectal cancer management from organ preservation to pelvic exenteration depending on tumour response to neoadjuvant therapy. However, careful attention is required in OP as local regrowth in up to 30% of cases reinforces the need for sustained active surveillance in Watch&Wait programmes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pelvic ExenterationRectal NeoplasmsNeoadjuvant TherapyFeasibility StudiesHumansFemaleMaleMiddle AgedAgedNeoplasm StagingOrgan Sparing TreatmentsTreatment OutcomeNeoplasm Recurrence, LocalAdult

Stichwörter der Autor:innen

Organ preservationPelvic exenterationRectal cancerTotal neoadjuvant therapy

Autor:innen und Institutionen

  • Bordeaux Colorectal Institute, Clinique Tivoli, 220 Rue Mandron, 33000, Bordeaux, France. christina.fleming49@gmail.com.
  • Department of Digestive Surgery, Colorectal Unit, Haut-Lévêque Hospital, Bordeaux University Hospital, Pessac, France. christina.fleming49@gmail.com.
  • Royal College of Surgeons in Ireland, Dublin, Ireland. christina.fleming49@gmail.com.
  • Bordeaux Colorectal Institute, Clinique Tivoli, 220 Rue Mandron, 33000, Bordeaux, France.
  • Department of Digestive Surgery, Colorectal Unit, Haut-Lévêque Hospital, Bordeaux University Hospital, Pessac, France.
  • Department of Urologic Surgery, Clinique Tivoli, Bordeaux, France.

Zitieren

APA

Fleming, C., Harji, D., Fernandez, B., François, M. O., Assenat, V., Gilles, P., Clément, M., Robert, G., & Denost, Q. (2024). Feasibility of a tailored operative strategy from organ preservation to pelvic exenteration for cT4 rectal cancer depending on neoadjuvant response. International Journal of Colorectal Disease. https://doi.org/10.1007/s00384-024-04675-y

Vancouver

Fleming C, Harji D, Fernandez B, François MO, Assenat V, Gilles P, et al. Feasibility of a tailored operative strategy from organ preservation to pelvic exenteration for cT4 rectal cancer depending on neoadjuvant response. International Journal of Colorectal Disease. 2024. doi:10.1007/s00384-024-04675-y

BibTeX
@article{Fleming2024,
  author = {Fleming, Christina and Harji, Deena and Fernandez, Benjamin and François, Marc-Olivier and Assenat, Vincent and Gilles, Pasticier and Clément, Michiels and Robert, Grégoire and Denost, Quentin},
  title = {Feasibility of a tailored operative strategy from organ preservation to pelvic exenteration for cT4 rectal cancer depending on neoadjuvant response},
  journal = {International Journal of Colorectal Disease},
  year = {2024},
  doi = {10.1007/s00384-024-04675-y}
}
Kostenlos starten →